Synch advised Innovestor Life Science Fund and Hadean Ventures on the deal. Gesynta Pharma completed a SEK 304 million funding round. The SEK 304 million secured...
Gesynta Pharma’s Investment Round
Ribbon Biolabs’ €18 Million Series A Financing Round
Herbst Kinsky advised Ribbon Biolabs on the deal, while Brandl Talos advised lead investor Hadean Ventures. Ribbon Biolabs announced its EUR 18 million Series A financing round...
Cardior Pharmaceuticals’ €64 Million Series B Financing Round
YPOG advised the consortium of investors on the deal, alongside with KNPZ. CMS advised Cardior Pharmaceuticals GmbH. Cardior Pharmaceuticals GmbH has closed a €64 million series B...
Step Pharma’s €35 Million Series B Financing
IN BRIEF: Alérion, Osborne Clarke, advised on the matter. Alérion advised Step Pharma with a team including Pierre-Olivier Brouard (Corporate M&A). Osborne Clarke advised Hadean Ventures,...




























